I have been getting a lot of requests for the slides discussed during my presentation at the Age Management Medicine Group’s spring conference in Hollywood, FL. I start with a brief introduction to the relevance of telomeres and telomerase activation to maintaining the healthspan and forestalling disease. This is followed by more detail about the current data supporting TA-65 as a telomerase activator in animal models and humans. Perhaps the most requested slides are those at the end of the lecture showing three of my own patients who have had gradual lengthening of their telomeres over the course of up to 4 years while on TA-65. If you have any questions or comments, please post them and I will answer them as soon as I can.